Cpwm, LLC Abbott Laboratories Transaction History

Cpwm, LLC

$1.06 Billion
Q3 2022

A detailed history of Cpwm, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Cpwm, LLC holds 31,723 shares of ABT stock, worth $3.24 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

31,723

Previous 31,196 1.69%

Holding current value

$3.24 Million

Previous $3.39 Million 9.41%

% of portfolio

0.29%

Previous 0.3%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $50,992 - $59,039	527 Added 1.69%	31,723 $3.07 Million
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $199,444 - $241,064	-1,954 Reduced 5.89%	31,196 $3.39 Million
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $34,320 - $41,851	-301 Reduced 0.9%	33,150 $3.92 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $13,299 - $14,712	-114 Reduced 0.34%	33,451 $3.95 Million
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $6,664 - $7,845	63 Added 0.19%	33,565 $3.89 Million

Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $36,787 - $43,341	338 Added 1.02%	33,502 $4.02 Million
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $17,010 - $18,536	162 Added 0.49%	33,164 $3.63 Million
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $6,873 - $8,346	-75 Reduced 0.23%	33,002 $3.59 Million
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $41,960 - $53,704	548 Added 1.68%	33,077 $3.02 Million
Q1 2020 May 11, 2020	BUY	$62.82 - $91.86 $47,491 - $69,446	756 Added 2.38%	32,529 $2.57 Million
Q4 2019 Feb 12, 2020	BUY	$78.51 - $87.4 $77,096 - $85,826	982 Added 3.19%	31,773 $2.76 Million
Q3 2019 Nov 13, 2019	BUY	$81.84 - $88.74 $20,623 - $22,362	252 Added 0.83%	30,791 $2.58 Million
Q2 2019 Aug 02, 2019	SELL	$72.88 - $85.0 $78,783 - $91,885	-1,081 Reduced 3.42%	30,539 $2.57 Million
Q1 2019 May 06, 2019	BUY	$66.22 - $80.06 $9,601 - $11,608	145 Added 0.46%	31,620 $2.53 Million
Q4 2018 Feb 08, 2019	SELL	$65.56 - $74.27 $2,425 - $2,747	-37 Reduced 0.12%	31,475 $2.28 Million
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $120,647 - $145,546	-1,984 Reduced 5.92%	31,512 $2.31 Million
Q2 2018 Dec 21, 2018	BUY	$57.57 - $63.54 $495,504 - $546,888	8,607 Added 34.58%	33,496 $2.04 Million
Q2 2018 Aug 09, 2018	SELL	$57.57 - $63.54 $478,233 - $527,826	-8,307 Reduced 25.02%	24,889 $1.52 Million
Q1 2018 Dec 21, 2018	BUY	$56.27 - $63.62 $648,117 - $732,775	11,518 Added 53.13%	33,196 $1.99 Million
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $181,020 - $204,665	-3,217 Reduced 12.92%	21,678 $1.3 Million
Q4 2017 Feb 02, 2018	SELL	$53.68 - $57.47 $26,893 - $28,792	-501 Reduced 1.97%	24,895 $1.42 Million
Q3 2017 Nov 14, 2017	SELL	$48.06 - $53.64 $143,266 - $159,900	-2,981 Reduced 10.5%	25,396 $1.36 Million
Q2 2017 Aug 14, 2017	BUY	N/A	28,377	28,377 $1.38 Million

Others Institutions Holding ABT

# of Institutions

3,130

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $179B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cpwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cpwm, LLC with notifications on news.

Account